
Is Recursion’s new London hub an epicentre of drug discovery?
Recursion has announced plans to open a new office in June 2024. The site will provide Recursion and Valence Labs, the company’s artificial intelligence (AI) research engine, with access to European talent and a life science ecosystem from which to work. Chris Gibson, Co-founder and CEO… Read More




